IRCCS Centro di Riferimento Oncologico della Basilicata (CROB)

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Multiple Myeloma Medicine & Life Sciences
Polycystic Ovary Syndrome Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
B-Cell Chronic Lymphocytic Leukemia Medicine & Life Sciences
Survival Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2018 2018

Research Output 1983 2019

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 othersFabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., Jan 1 2019, In : European Journal of Cancer.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival
1 Citation (Scopus)

A GBM-like V-ATPase signature directs cell-cell tumor signaling and reprogramming via large oncosomes

Bertolini, I., Terrasi, A., Martelli, C., Gaudioso, G., Di Cristofori, A., Storaci, A. M., Formica, M., Braidotti, P., Todoerti, K., Ferrero, S., Caroli, M., Ottobrini, L., Vaccari, T. & Vaira, V., Mar 1 2019, In : EBioMedicine. 41, p. 225-235 11 p.

Research output: Contribution to journalArticle

Open Access
Glioblastoma
Adenosine Triphosphatases
Tumors
Glioma
Neoplasms

Are novel outcome measures for Charcot–Marie–Tooth disease sensitive to change? The 6-minute walk test and StepWatch™ Activity Monitor in a 12-month longitudinal study

Pazzaglia, C., Padua, L., Pareyson, D., Schenone, A., Aiello, A., Fabrizi, G. M., Cavallaro, T., Santoro, L., Manganelli, F., Coraci, D., Gemignani, F., Vitetta, F., Quattrone, A., Mazzeo, A., Russo, M., Vita, G. & Group, F. T. CMT-TRIAAL., 2019, In : Neuromuscular Disorders.

Research output: Contribution to journalArticle